Krystal Biotech Inc (KRYS) Implied Volatility Current

Tracking KRYS implied volatility helps you identify when options premiums on Krystal Biotech Inc are historically cheap or expensive, and where the best trades are hiding. Krystal Biotech Inc implied volatility reflects the market's expectation of future price movement: when KRYS IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Krystal Biotech Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For KRYS, tracking metrics like KRYS IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on KRYS signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome.

Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where KRYS implied volatility sits today versus where it has been. Our scanner ranks Krystal Biotech Inc implied volatility against its historical range, surfaces extremes in KRYS IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Krystal Biotech Inc IV is rich or cheap — measure it, then act on it.